home / stock / skye / skye quote
Last: | $14.81 |
---|---|
Change Percent: | -5.81% |
Open: | $15.67 |
Close: | $14.81 |
High: | $16.01 |
Low: | $14.005 |
Volume: | 216,501 |
Last Trade Date Time: | 04/22/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$14.81 | $15.67 | $14.81 | $16.01 | $14.005 | 216,501 | 04-22-2024 |
$16.14 | $16.22 | $16.14 | $17.4 | $14.2376 | 105,077 | 04-19-2024 |
$16.97 | $17.37 | $16.97 | $17.6473 | $16.26 | 69,556 | 04-18-2024 |
$17.36 | $16.95 | $17.36 | $17.4772 | $16.4 | 87,599 | 04-17-2024 |
$16.25 | $13 | $16.25 | $16.43 | $12.97 | 100,895 | 04-16-2024 |
$13 | $12.91 | $13 | $13 | $12.48 | 53,715 | 04-15-2024 |
$12.91 | $12.83 | $12.91 | $13.3788 | $12.3801 | 51,807 | 04-12-2024 |
$12.69 | $13.5 | $12.69 | $13.7128 | $11.04 | 17,581 | 04-11-2024 |
$12.81 | $9.8 | $12.81 | $14.1975 | $9.547 | 23,348 | 04-10-2024 |
$9.17 | $8.86 | $9.17 | $9.2327 | $8.25 | 26,811 | 04-09-2024 |
$9.59 | $9.05 | $9.59 | $10.25 | $8.8 | 26,719 | 04-08-2024 |
$9.05 | $11.4 | $9.05 | $11.99 | $7.35 | 74,290 | 04-05-2024 |
$11.08 | $13.25 | $11.08 | $13.35 | $11.04 | 53,930 | 04-04-2024 |
$13.39 | $14.13 | $13.39 | $14.18 | $13 | 19,135 | 04-03-2024 |
$14.1 | $14 | $14.1 | $14.56 | $13.51 | 2,314 | 04-02-2024 |
$14.18 | $14.14 | $14.18 | $15.59 | $13.54 | 6,072 | 04-01-2024 |
$15.64 | $14.34 | $15.64 | $15.745 | $14.34 | 26,253 | 03-29-2024 |
$15.64 | $14.34 | $15.64 | $15.745 | $14.34 | 26,253 | 03-28-2024 |
$14.34 | $13.75 | $14.34 | $14.34 | $13.67 | 2,721 | 03-27-2024 |
$13.77 | $13.45 | $13.77 | $14.4 | $13 | 13,991 | 03-26-2024 |
News, Short Squeeze, Breakout and More Instantly...
Skye Bioscience Inc Com Company Name:
SKYE Stock Symbol:
OTCMKTS Market:
SAN DIEGO, April 30, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid system, today annou...
SAN DIEGO, April 23, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (NASDAQ:SKYE) ("Skye"), a clinical-stage biotechnology company focused on th...
SAN DIEGO, April 23, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid system, today annou...